MediGouvy: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MediGouvy
Largest movements
- Tangible fixed assets -€13,687
down €13,687 (-4.4%), from €311,662 to €297,975
- Cash +€4,532
up €4,532 (+81.9%), from €5,536 to €10,068
mainly Depreciation (+€13,687) and Net result for the year (+€5,816)
- Debts after one year -€16,976
down €16,976 (-7.4%), from €230,264 to €213,288
- Profit (loss) carried forward +€5,433
up €5,433 (+30.4%), from -€17,885 to -€12,452
- Gross operating margin +€5,120
up €5,120 (+23.0%), from €22,230 to €27,351
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €317,935 | €308,434 | -€9,502 | -3.0% |
| Fixed assets | 21/28 | €311,662 | €297,975 | -€13,687 | -4.4% |
| Tangible fixed assets | 22/27 | €311,662 | €297,975 | -€13,687 | -4.4% |
| Land and buildings | 22 | €311,662 | €297,975 | -€13,687 | -4.4% |
| Current assets | 29/58 | €6,273 | €10,458 | +€4,185 | +66.7% |
| Cash at bank and in hand | 54/58 | €5,536 | €10,068 | +€4,532 | +81.9% |
| Deferred charges and accrued income | 490/1 | €737 | €390 | -€347 | -47.1% |
| Total equity and liabilities | 10/49 | €317,935 | €308,434 | -€9,502 | -3.0% |
| Equity | 10/15 | €32,115 | €37,548 | +€5,433 | +16.9% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€17,885 | -€12,452 | +€5,433 | +30.4% |
| Amounts payable | 17/49 | €285,821 | €270,885 | -€14,935 | -5.2% |
| Amounts payable after more than one year | 17 | €230,264 | €213,288 | -€16,976 | -7.4% |
| Financial debts | 170/4 | €230,264 | €213,288 | -€16,976 | -7.4% |
| Amounts payable within one year | 42/48 | €55,557 | €57,597 | +€2,040 | +3.7% |
| Current portion of amounts payable after more than one year | 42 | €16,740 | €16,976 | +€236 | +1.4% |
| Taxes, remuneration and social security | 45 | €859 | €799 | -€60 | -7.0% |
| Taxes | 450/3 | €859 | €799 | -€60 | -7.0% |
| Other amounts payable | 47/48 | €37,958 | €39,823 | +€1,865 | +4.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €13,687 | €13,687 | = | 0.0% |
| Other operating charges | 640/8 | €2,023 | €2,122 | +€98 | +4.9% |
| Gross operating margin | 9900 | €22,230 | €27,351 | +€5,120 | +23.0% |
| Operating profit (loss) | 9901 | €6,520 | €11,542 | +€5,022 | +77.0% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €5,601 | €5,726 | +€125 | +2.2% |
| Recurring financial charges | 65 | €5,601 | €5,726 | +€125 | +2.2% |
| Profit (loss) for the period before taxes | 9903 | €920 | €5,816 | +€4,897 | +532% |
| Profit (loss) for the period | 9904 | €920 | €5,816 | +€4,897 | +532% |
| Profit (loss) for the period to be appropriated | 9905 | €920 | €5,816 | +€4,897 | +532% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.